Frank E, Kupfer D J, Siegel L R
Department of Psychiatry, University of Pittsburgh School of Medicine, PA 15213.
J Clin Psychiatry. 1995;56 Suppl 1:11-6; discussion 16-7.
Over the last decade, our clinical research team has evolved effective methods for forming a strong treatment alliance with mood disorder patients. These methods, in turn, have been associated with very low rates of patient dropout (< 10%) and high rates of objectively measured medication compliance (> 85%) over multiyear treatment trials. We have every reason to believe that our technique for alliance building would be equally effective in general clinical practice. The cornerstones of our methods are education of, information for, and active participation by the patient in the treatment process. We begin by educating the patient about his or her disorder and its treatment, giving patients as much information as their clinical condition will allow them to absorb. As patients begin to improve, we provide additional information. We continuously inform patients about what to expect in treatment and when, both with respect to amelioration of symptoms and with respect to the medication side effects they may experience. We present the treatment experience as an experiment in which clinician and patient are coinvestigators, each with his or her own expertise. The clinician is the expert on the disorder and its treatment in general; the patient is the expert on his or her own disorder and his or her own experience of the treatment. We try to keep the experiment interesting and, whenever possible, to inject some humor into it. We work to engage family members as adjunct members of the experimental team by educating them as well and keeping them informed throughout the treatment process.(ABSTRACT TRUNCATED AT 250 WORDS)
在过去十年中,我们的临床研究团队已经开发出了有效的方法,以便与情绪障碍患者建立牢固的治疗联盟。在多年的治疗试验中,这些方法反过来又与极低的患者退出率(<10%)以及客观测量的高药物依从率(>85%)相关联。我们完全有理由相信,我们建立联盟的技术在一般临床实践中同样有效。我们方法的基石是患者在治疗过程中的教育、信息提供以及积极参与。我们首先向患者介绍其疾病及其治疗方法,在患者临床状况允许的情况下,尽可能多地向他们提供信息。随着患者开始好转,我们会提供更多信息。我们不断告知患者治疗中会发生什么以及何时发生,包括症状改善方面以及他们可能经历的药物副作用方面。我们将治疗体验呈现为一项实验,临床医生和患者都是共同研究者,各自拥有自己的专业知识。临床医生总体上是疾病及其治疗方面的专家;患者则是自身疾病以及自身治疗体验方面的专家。我们努力让实验变得有趣,并尽可能地在其中融入一些幽默。我们通过教育家庭成员并在整个治疗过程中让他们了解情况,努力使他们成为实验团队的辅助成员。(摘要截选于250词)